Projects funded by the NCN
The significance of cancer specific PFK-II (PFKFB3 and PFKFB4) isoenzymes inhibition in overcoming resistance to BRAF inhibitors in malignant melanoma therapy
2018/31/N/NZ5/03561
Keywords:
6-phosphofructo-20kinase/fructose-2,6-bisphosphatase malignant melanoma glucose metabolism BRAF inhibitors
Descriptors:
- NZ5_3:
- NZ5_7:
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 3
Call: PRELUDIUM 16 - announced on 2018-09-14
Amount awarded: 209 929 PLN
Project start date (Y-m-d): 2019-08-01
Project end date (Y-m-d): 2024-07-31
Project duration:: 36 months (the same as in the proposal)
Project status: Project completed
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publications will be made available after the final report has been accepted.